Clinical Trial Update: Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study [Phase 3]

View source ↗

Summary

Phase 3 outcome study comparing lanthanum carbonate with calcium carbonate in hemodialysis patients with hyperphosphatemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease with Hyperphosphatemia
• Hemodialysis-related Hyperphosphatemia

Drugs mentioned

• Calcium carbonate (Calcium carbonate)
• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Hemodialysis, Hyperphosphatemia | Phase 3 | Status: COMPLETED